C P Girish Kumar
Overview
Explore the profile of C P Girish Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
774
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Babu H, Rachel G, Neogi U, Palaniappan A, Narayanan A, Ponnuraja C, et al.
Metab Brain Dis
. 2024 Nov;
40(1):32.
PMID: 39570517
People living with HIV (PLHIV) are known to be at a higher risk of developing an array of aging-related diseases despite well-adhered combined antiretroviral therapy (cART). The present study aimed...
2.
Charles P, Kumar S, Kumar C, Parameswaran S, Viswanathan P, Ganesh R
J Med Microbiol
. 2024 Nov;
73(11).
PMID: 39540836
The existence of a mutual relationship between gut microbiota and immune homeostasis highlights its importance in the context of kidney transplantation. The translational utility of gut microbiota as a biomarker...
3.
Kumar C, Bhatnagar T, Sathya Narayanan G, Swathi S, Sindhuja V, Siromany V, et al.
Clin Infect Dis
. 2024 Sep;
77(Suppl 1):S111-S117.
PMID: 39248528
Background: Antimicrobial resistance poses a significant threat to public health globally. We studied the prevalence of colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE), carbapenem-resistant Enterobacterales (CRE), and colistin-resistant Enterobacterales (Col-RE) in...
4.
Kumar N, Banurekha V, Kumar C, Nancy A, Padmapriyadarsini C, Shankar S, et al.
J Travel Med
. 2022 Jul;
29(6).
PMID: 35900009
Background: Covaxin/BBV152 is one of the most widely used vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and one of the few vaccines used extensively in low- and...
5.
Thangaraj J, Kumar M, Kumar C, Yadav P, Rani D, Karunakaran T, et al.
Front Public Health
. 2022 Apr;
10:836454.
PMID: 35444976
India witnessed a very strong second wave of coronavirus disease 2019 (COVID-19) during March and June 2021. Newly emerging variants of concern can escape immunity and cause reinfection. We tested...
6.
Kumar N, Moideen K, Nancy A, Selvaraj N, Renji R, Munisankar S, et al.
Viruses
. 2022 Mar;
14(3).
PMID: 35336918
Background: Examination of CD4+ T cell responses during the natural course of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection offers useful information for the improvement of vaccination strategies against this...
7.
Murhekar M, Bhatnagar T, Thangaraj J, Saravanakumar V, Kumar M, Selvaraju S, et al.
PLoS Med
. 2021 Dec;
18(12):e1003877.
PMID: 34890407
Background: India began COVID-19 vaccination in January 2021, initially targeting healthcare and frontline workers. The vaccination strategy was expanded in a phased manner and currently covers all individuals aged 18...
8.
Rajamanickam A, Kumar N, Nancy Pandiarajan A, Selvaraj N, Munisankar S, Renji R, et al.
Sci Rep
. 2021 Oct;
11(1):20254.
PMID: 34642411
Monocytes are thought to play an important role in host defence and pathogenesis of COVID-19. However, a comprehensive examination of monocyte numbers and function has not been performed longitudinally in...
9.
Rajamanickam A, Kumar N, Nancy P A, Selvaraj N, Munisankar S, Renji R, et al.
Am J Trop Med Hyg
. 2021 Sep;
105(5):1255-1260.
PMID: 34583334
It is essential to examine the longevity of the defensive immune response engendered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We examined the SARS-CoV-2-specific antibody responses and ex vivo...
10.
Thangaraj J, Kumar M, Velusamy S, Kumar C, Selvaraju S, Sabarinathan R, et al.
Indian J Med Res
. 2021 Sep;
153(5&6):546-549.
PMID: 34528527
Background & Objectives: Infection fatality ratio (IFR) is considered a more robust and reliable indicator than case fatality ratio for severity of SARS-CoV-2 infection. Age- and sex-stratified IFRs are crucial...